FI940393A7 - Kinatsoliinijohdannaiset asetyylikoliiniesteraasi-inhibiittoreina - Google Patents
Kinatsoliinijohdannaiset asetyylikoliiniesteraasi-inhibiittoreina Download PDFInfo
- Publication number
- FI940393A7 FI940393A7 FI940393A FI940393A FI940393A7 FI 940393 A7 FI940393 A7 FI 940393A7 FI 940393 A FI940393 A FI 940393A FI 940393 A FI940393 A FI 940393A FI 940393 A7 FI940393 A7 FI 940393A7
- Authority
- FI
- Finland
- Prior art keywords
- quinazoline derivatives
- acetylcholinesterase inhibitors
- acetylcholinesterase
- inhibitors
- quinazoline
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73688891A | 1991-07-29 | 1991-07-29 | |
| US91166292A | 1992-07-16 | 1992-07-16 | |
| PCT/US1992/005864 WO1993003034A1 (en) | 1991-07-29 | 1992-07-22 | Quinazoline derivatives as acetylcholinesterase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI940393A0 FI940393A0 (fi) | 1994-01-26 |
| FI940393A7 true FI940393A7 (fi) | 1994-03-11 |
Family
ID=27113138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940393A FI940393A7 (fi) | 1991-07-29 | 1994-01-26 | Kinatsoliinijohdannaiset asetyylikoliiniesteraasi-inhibiittoreina |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5486512A (cs) |
| EP (1) | EP0597956A1 (cs) |
| JP (1) | JPH06509576A (cs) |
| AU (1) | AU665207B2 (cs) |
| CA (1) | CA2113115A1 (cs) |
| CZ (1) | CZ281628B6 (cs) |
| FI (1) | FI940393A7 (cs) |
| HU (1) | HUT66324A (cs) |
| IE (1) | IE922434A1 (cs) |
| MX (1) | MX9204425A (cs) |
| NO (1) | NO940305L (cs) |
| PT (1) | PT100742A (cs) |
| WO (1) | WO1993003034A1 (cs) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1311272B1 (en) * | 2000-03-03 | 2006-11-22 | Eisai Co., Ltd. | Novel methods using cholinesterase inhibitors |
| US20030153598A1 (en) * | 2000-07-25 | 2003-08-14 | Raymond Pratt | Methods for treating Parkinson's disease with cholinesterase inhibitors |
| US20030229072A1 (en) * | 2000-09-07 | 2003-12-11 | Bullock William H | Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents |
| US7022844B2 (en) | 2002-09-21 | 2006-04-04 | Honeywell International Inc. | Amide-based compounds, production, recovery, purification and uses thereof |
| EP1746999B1 (en) | 2004-05-06 | 2011-11-16 | Warner-Lambert Company LLC | 4-phenylamino-quinazolin-6-yl-amides |
| AU2005322611A1 (en) * | 2004-12-23 | 2006-07-06 | Voyager Pharmaceutical Corporation | Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of Alzheimer's disease |
| US20070155738A1 (en) * | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| WO2006128184A2 (en) * | 2005-05-20 | 2006-11-30 | Alantos-Pharmaceuticals, Inc. | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| EP2091948B1 (en) | 2006-11-30 | 2012-04-18 | Probiodrug AG | Novel inhibitors of glutaminyl cyclase |
| EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
| EP2865670B1 (en) | 2007-04-18 | 2017-01-11 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
| CN101220043A (zh) * | 2008-01-24 | 2008-07-16 | 沈阳药科大学 | 噻唑并[3,2-a]嘧啶类衍生物及其应用 |
| CN102695546B (zh) | 2009-09-11 | 2014-09-10 | 前体生物药物股份公司 | 作为谷氨酰胺酰环化酶抑制剂的杂环衍生物 |
| EP2533645B1 (en) | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
| DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
| JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| JP6050264B2 (ja) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| EP2919788A4 (en) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA |
| HK1217092A1 (zh) | 2013-02-15 | 2016-12-23 | Kala Pharmaceuticals, Inc. | 治疗性化合物及其用途 |
| CA2900680C (en) | 2013-02-20 | 2021-08-10 | Kala Pharmaceuticals, Inc. | Quinoline and quinazoline compounds and uses thereof for treating and/or preventing diseases |
| US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| ES2881081T3 (es) | 2013-03-15 | 2021-11-26 | Agenebio Inc | Procedimientos y composiciones para mejorar la función cognitiva |
| NZ719185A (en) | 2013-11-01 | 2017-11-24 | Kala Pharmaceuticals Inc | Crystalline forms of therapeutic compounds and uses thereof |
| US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| CN112843005B (zh) | 2015-05-22 | 2023-02-21 | 艾吉因生物股份有限公司 | 左乙拉西坦的延时释放药物组合物 |
| UA121503C2 (uk) | 2015-06-26 | 2020-06-10 | Такеда Фармасьютікал Компані Лімітед | 2,3-дигідро-4h-1,3-бензоксазин-4-онові похідні як модулятори холінергічного мускаринового рецептора m1 |
| US10548899B2 (en) | 2015-10-20 | 2020-02-04 | Takeda Pharmaceutical Company Limited | Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity |
| EP3509423A4 (en) | 2016-09-08 | 2020-05-13 | Kala Pharmaceuticals, Inc. | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |
| CA3036336A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
| EP3509421A4 (en) | 2016-09-08 | 2020-05-20 | Kala Pharmaceuticals, Inc. | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |
| EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2992221A (en) * | 1958-07-03 | 1961-07-11 | Petersen Siegfried | Polymethylene-oxoquinazolines and their production |
| US3271396A (en) * | 1964-08-17 | 1966-09-06 | Squibb & Sons Inc | Pyrido-quinazoline derivatives |
| US3745216A (en) * | 1969-12-18 | 1973-07-10 | Smith Kline French Lab | Compositions and methods for producing hypotensive activity with imidazo and pyrimido(2,1-b)quinazoline compounds |
| US3932407A (en) * | 1973-11-19 | 1976-01-13 | Bristol-Myers Company | Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones |
| BE794964A (fr) * | 1972-02-04 | 1973-08-02 | Bristol Myers Co | Nouveaux agents hypotenseurs et procede pour les preparer |
| JPS5752352B2 (cs) * | 1974-02-28 | 1982-11-06 | ||
| NL7807507A (nl) * | 1977-07-25 | 1979-01-29 | Hoffmann La Roche | Tricyclische verbindingen. |
| HU182009B (en) * | 1977-08-19 | 1983-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing substituted pirido-square bracket-1,2-a-square bracket closed-pyrimidines, pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines |
| DE2845766A1 (de) * | 1978-10-18 | 1980-04-30 | Schering Ag | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
| AT377586B (de) * | 1981-06-30 | 1985-04-10 | Erba Farmitalia | Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen |
| FR2512674B1 (fr) * | 1981-09-16 | 1986-01-10 | Sandoz Sa | Nouveaux derives tricycliques de la quinazolinone, leur preparation et medicaments contenant ces derives |
| US4395554A (en) * | 1981-12-01 | 1983-07-26 | Mobil Oil Corporation | Process for producing alpha-picoline |
| ZA851131B (en) * | 1984-02-15 | 1986-09-24 | Syntex Inc | (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)oxyalkylamides |
| US4783467A (en) * | 1985-06-05 | 1988-11-08 | Pfizer Inc. | Tetrahydroimidazoquinazolinone inotropic agents |
| US4837239A (en) * | 1985-08-23 | 1989-06-06 | Syntex (U.S.A.) Inc. | Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins |
| US4670434A (en) * | 1985-11-14 | 1987-06-02 | Syntex (U.S.A.) Inc. | (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors |
| US4766126A (en) * | 1986-01-10 | 1988-08-23 | Daiichi Seiyaku Co., Ltd. | Process for treatment of nephritis with imidazoquinazolines |
| US4760065A (en) * | 1986-02-13 | 1988-07-26 | Hardtmann Goetz E | Trifluoromethyl substituted tetracyclic quinazolin-ones having tranquilizing activity |
-
1992
- 1992-07-22 EP EP92916726A patent/EP0597956A1/en not_active Withdrawn
- 1992-07-22 JP JP5503581A patent/JPH06509576A/ja active Pending
- 1992-07-22 CA CA002113115A patent/CA2113115A1/en not_active Abandoned
- 1992-07-22 CZ CZ94135A patent/CZ281628B6/cs unknown
- 1992-07-22 WO PCT/US1992/005864 patent/WO1993003034A1/en not_active Application Discontinuation
- 1992-07-22 AU AU23978/92A patent/AU665207B2/en not_active Ceased
- 1992-07-22 HU HU9400258A patent/HUT66324A/hu unknown
- 1992-07-24 IE IE243492A patent/IE922434A1/en not_active Application Discontinuation
- 1992-07-29 MX MX9204425A patent/MX9204425A/es unknown
- 1992-07-29 PT PT100742A patent/PT100742A/pt not_active Application Discontinuation
-
1994
- 1994-01-26 FI FI940393A patent/FI940393A7/fi not_active Application Discontinuation
- 1994-01-28 NO NO940305A patent/NO940305L/no unknown
- 1994-03-17 US US08/214,911 patent/US5486512A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MX9204425A (es) | 1993-01-01 |
| CA2113115A1 (en) | 1993-02-18 |
| AU2397892A (en) | 1993-03-02 |
| US5486512A (en) | 1996-01-23 |
| FI940393A0 (fi) | 1994-01-26 |
| WO1993003034A1 (en) | 1993-02-18 |
| CZ13594A3 (en) | 1994-05-18 |
| HUT66324A (en) | 1994-11-28 |
| EP0597956A1 (en) | 1994-05-25 |
| NO940305L (no) | 1994-03-28 |
| CZ281628B6 (cs) | 1996-11-13 |
| PT100742A (pt) | 1993-10-29 |
| AU665207B2 (en) | 1995-12-21 |
| HU9400258D0 (en) | 1994-06-28 |
| JPH06509576A (ja) | 1994-10-27 |
| NO940305D0 (no) | 1994-01-28 |
| IE922434A1 (en) | 1993-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI940393A7 (fi) | Kinatsoliinijohdannaiset asetyylikoliiniesteraasi-inhibiittoreina | |
| CY2004008I2 (el) | ΠΑΡΑΓΩΓΑ ΠΥΡΙΜΙΔΙΝΗΣ ΣΑΝ ΑΝΑΣΤΟΛΕΙΣ HMG-CoA ΑΝΑΓΩΓΑΣΗΣ | |
| ATE182147T1 (de) | Substituierte thiazolidindion derivate | |
| FI933303L (fi) | Adenosinkinasinhibitorer | |
| FI930208L (fi) | Kinazolinderivat | |
| FI935431A7 (fi) | Kiantsoliinijohdannaisia | |
| FI980341L (fi) | 2-oksi-indolijohdannaisia | |
| ATA75293A (de) | Indolderivate | |
| DK0606248T3 (da) | Heteroarylaminer som hidtil ukendte acetylcholinesteraseinhibitorer | |
| FI933037A7 (fi) | Tiazolylvinylfenylderivat | |
| FI943727L (fi) | Piperidinyylitiasyklisiä johdannaisia | |
| LV5806B4 (lv) | LHL antagonisti | |
| FI941423A7 (fi) | 17beta-substituoidut 4-atsa-5alfa-androstan-3-onijohdannaiset | |
| FI940573L (fi) | Geneseriinin johdannaiset koliiniestraasin inhibiittoreina | |
| FI921262L (fi) | 4-aryltiazol- eller 4-arylimidazolderivat | |
| FI940469A7 (fi) | Kinoliinijohdannaisia immunostimulantteina | |
| DE69330497D1 (de) | Chinazolin-derivate | |
| FI952722A7 (fi) | Allergian vastaisia triatsolobentsatsepiinijohdannaisia | |
| FI950089A7 (fi) | Dioksosyklobuteenijohdannaiset angiotensiini-II-antagonisteina | |
| FI20010214L (fi) | Asyyliaminoindolijohdannaisia | |
| FI953851L (fi) | Silybidut asetyylikoliiniesteraase-inhibiittorit | |
| DE59308714D1 (de) | Cyclobutan-benzol-derivate | |
| FI20002460L (fi) | 4-difenyylimetyylipiperidiinijohdannaisia | |
| NO930520D0 (no) | Bifenyl-substituerte kinolinderivater | |
| DK0409676T3 (da) | Acetylcholinesterase-inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |